AAAAAA

   
Results: 1-11 |
Results: 11
ARE RISK-FACTORS FOR STROKE AND CORONARY-DISEASE THE SAME
Authors: QIZILBASH N
Citation: N. Qizilbash, ARE RISK-FACTORS FOR STROKE AND CORONARY-DISEASE THE SAME, Current opinion in lipidology, 9(4), 1998, pp. 325-328
CHOLINESTERASE INHIBITION FOR ALZHEIMER-DISEASE - A METAANALYSIS OF THE TACRINE TRIALS
Authors: QIZILBASH N WHITEHEAD A HIGGINS J WILCOCK G SCHNEIDER L FARLOW M
Citation: N. Qizilbash et al., CHOLINESTERASE INHIBITION FOR ALZHEIMER-DISEASE - A METAANALYSIS OF THE TACRINE TRIALS, JAMA, the journal of the American Medical Association, 280(20), 1998, pp. 1777-1782
REPEAT MEASUREMENT OF CASE-CONTROL DATA - CORRECTIONS FOR MEASUREMENTERROR IN A STUDY OF ISCHEMIC STROKE AND HEMOSTATIC FACTORS
Authors: BASHIR SA DUFFY SW QIZILBASH N
Citation: Sa. Bashir et al., REPEAT MEASUREMENT OF CASE-CONTROL DATA - CORRECTIONS FOR MEASUREMENTERROR IN A STUDY OF ISCHEMIC STROKE AND HEMOSTATIC FACTORS, International journal of epidemiology, 26(1), 1997, pp. 64-70
VON-WILLEBRAND-FACTOR AND RISK OF ISCHEMIC STROKE
Authors: QIZILBASH N DUFFY S PRENTICE CRM BOOTHBY M WARLOW C
Citation: N. Qizilbash et al., VON-WILLEBRAND-FACTOR AND RISK OF ISCHEMIC STROKE, Neurology, 49(6), 1997, pp. 1552-1556
CHOLESTEROL AND RISK OF STROKE - REPLY
Authors: QIZILBASH N LEWINGTON S PETO R
Citation: N. Qizilbash et al., CHOLESTEROL AND RISK OF STROKE - REPLY, Lancet, 347(9003), 1996, pp. 762-762
EVIDENCE-BASED MEDICINE - SYSTEMATIC REVI EWS - THE COCHRANE COLLABORATION
Authors: ARRIETA JML QIZILBASH N
Citation: Jml. Arrieta et N. Qizilbash, EVIDENCE-BASED MEDICINE - SYSTEMATIC REVI EWS - THE COCHRANE COLLABORATION, Medicina Clinica, 107(15), 1996, pp. 581-585
STROKE AND CHOLESTEROL
Authors: QIZILBASH N ARRIETA JML
Citation: N. Qizilbash et Jml. Arrieta, STROKE AND CHOLESTEROL, Revista Clinica Espanola, 196(6), 1996, pp. 347-348
FIBRINOGEN AND CEREBROVASCULAR-DISEASE
Authors: QIZILBASH N
Citation: N. Qizilbash, FIBRINOGEN AND CEREBROVASCULAR-DISEASE, European heart journal, 16, 1995, pp. 42-46
CHOLESTEROL, DIASTOLIC BLOOD-PRESSURE, AND STROKE - 13000 STROKES IN 450000 PEOPLE IN 45 PROSPECTIVE COHORTS
Authors: QIZILBASH N LEWINGTON S DUFFY S PETO R SMITH T SPIEGELHALTER D ISO H SHIMAMOTO T KOMACHI Y IIDA M DOYLE J STROGATZ D EBRAHIM S WANNAMETHEE G WHINCUP P BURKE V CULLEN K KNUIMAN M WELBORN T BAINTON D BAKER I ELWOOD P SWEETNAM P YARNELL J KEIL J SUTHERLAND S HAMES C TYROLER H DAGOSTINO R KANNEL W WOLF P AROMAA A KNEKT P MAATELA J REUNANEN A PUSKA P SARTI C TAMMINEN M TUOMILEHTO J VARTIAINEN E BENGTSSON C BJORKELUND C LISSNER L KODAMA K SHIMIZU Y KAGAN A POPPER J REED D YANO K GOLDBOURT U MEDALIE J YAARI S CRIQUI M DAVIS C BLACKBURN H JACOBS D LEUPKER R HARRIS T MADANS J OFSTEDAL M BJARTVEIT K STENSVOLD I TVERDAL A GARROW K MEADE T RUDDOCK V HAHEIM L HJERMANN I HOLME I LEREN P CAMBIEN F DUCIMETIERE P RICHARD J ASSMANN G BARRETTCONNOR E LANGER R GILLIS C HART C HAWTHORNE V HOLE D ISLES C LEVER A SMITH GD ARAVANIS C BLACKBURN H BUZINA R DONTAS A FIDANZA F GIAMPAOLI S KARVONEN M KEYS A KROMHOUT D LANTI M MENOTTI A MOHACEK I NEDELJKOVIC S NISSINEN A PUNSAR S SECCARECCIA F TOSHIMA H CHEN Z COLLINS R LI W LU J DATE C NAKAYAMA T TANAKA H YOKOYAMA T YOSHIIKE N BROWN C TUNSTALLPEDOE H HIGGINS M KELLER J CARSTENSEN J TORNBERG S MARMOT M SHIPLEY M
Citation: N. Qizilbash et al., CHOLESTEROL, DIASTOLIC BLOOD-PRESSURE, AND STROKE - 13000 STROKES IN 450000 PEOPLE IN 45 PROSPECTIVE COHORTS, Lancet, 346(8991-2), 1995, pp. 1647-1653
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Authors: ALTMAN R CARRERAS L DIAZ R FIGUEROA E PAOLASSO E PARODI JC CADE JF DONNAN G EADIE MJ GAVAGHAN TP OSULLIVAN EF PARKIN D RENNY JTG SILAGY C VINAZZER H ZEKERT F ADRIAENSEN H BERTRANDHARDY JM BRAN M DAVID JL DRICOT J LAVENNEPARDONGE E LIMET R LOWENTHAL A MORIAU M SCHAPIRA S SMETS P SYMOENS J VERHAEGHE R VERSTRAETE M ATALLAH A BARNETT H BATISTA R BLAKELY J CAIRNS JA COTE R CROUCH J EVANS G FINDLAY JM GENT M LANGLOIS Y LECLERC J NORRIS J PINEO GF POWERS PJ ROBERTS R SCHWARTZ L SICURELLA J TAYLOR W THEROUX P TURPIE AG WEISEL RD CUI J LIU L PIRK J BAY C BOYSEN G KNUDSEN JB PETERSEN P SORENSEN PS TONNESEN HK HARJOLA PT ARCAN JC BALKAU B BLANCHARD J BOISSEL JP BONEU B BOUSSER MG BROCHIER M CLOAREC M CRIBIER G DECHAVANNE M DROUIN P ESCHWEGE E GUIRAUDCHAUMEIL B HUGONOT R LEIZOROVICZ A LORIA Y MICHAT L MIROUZE J PANAK E PASTEYER J RASCOL A REVOL L ROY M SELLES J SLAMA G STARKMAN C TEULE M THIBULT N VERRY M ALBERT FW ANDRASSY K BREDDIN K ECKEL R ENCKE A FROHLICH J HARTUNG B HEISS HW HESS H HOFLING B KRAUSE D LATTA G LINKE H LOEW D LORENZ R MIDDLETON K NOVAK G OLDENDORF M PFLUGER N RAITHEL D REUTER R SCHETTLER G SCHNITKER J SCHOOP W STIEGLER H UBERLA K VOGEL G WEBER M WELBERS I ZEITLER E ARAPAKIS G CHAN T MOK CK SZABO R MISRA NP REDDY K FITZGERALD GA APOLLONIO A BALSANO F BASELLINI A CANDELISE L CATALANO M CIAVARELLA N CIUFFETTI G COCCHERI S CORTELLARO M CORVI G COTO V DAVI G DECATERINA R DIPERRI T FIESCHI C GENTILE R GREGORATTI L GRESELE P LAVEZZARI M LIBRETTI A MAGNANI B NENCI G PAGANO G PATRONO C PEDRINI L PINI M PRANDONI P ROMEO F ROVELLI F RUDELLI G RUVOLO G SIGNORINI GP TOGNONI G VIOLI F FUJIMORI T KAGEYAMA M KATSUMURA T KITAMURA S MAEDA K SUZUKI A TOHGI H UCHIYAMA S UTSUMI H GARCIA AM ALGRA A DENOTTOLANDER GJH KUPPER AJF VANGIJN J HART H KAPPELLE LJ KOUDSTAAL PJ LEMMENS T LODDER J PANNEBAKKER M SERRUYS PW VANDENBELT A VANDERMEER J VANDERVIJGH AB VERHEUGT FWA VETH G DALE J JOHANNESSEN KA THAULOW E POPESCU P TIBERIU N AZNAR JRD ESMATJES E GUITERAS P LASIERRA J LOPEZTRIGO P ORIOL A POMAR L ROCHA E SANCHEZ FD SANCHORIEGER J SANZ G BERGLUND ULF BLOMSTRAND C BOBERG M BRITTON M ELWIN CE HELMERS C HOLM J JANZON L JUULMOLLER S MULEC H OLSSON JE PERSSON S RASMANIS G ROSEN A SAMUELSSON K SOREFF J WAHLGREN N WALLENTIN L BAUR HR BOKSLAG M BOLLINGER A MEIER B PFISTERER M PFLUGER N SITTHIAMORN C ACHESON EJ APPLEBY P ASSCHER AW AUKLAND A BAIGENT C BALA S BARNETT AH BELL P BEWS S BORN GVR BRANAGAN JP BROOKS N BROWN MJ BROWSE NL CAPILDEO R CARMALT M CARTER AE CHALMERS I CLARKE M CLARKE RJ CLYNE CAC COLLINS R COOKE ED COUTTS G COVE DH CROWTHER PS CUTHBERTSON WF DEBONO D DICKERSON C DICKINSON JP DOLL R DORMANDY JA DUNBABIN D ELL S ELPHINSTONE P ELWOOD P ENGLISHBY V FARRELL B FISKERSTRAND C FLATHER M FOLEY T FOULDS T FOX KM FRANKS P FRASER H GARDECKI T GAWEL M GENT AE GERSHLICK AH GODWIN J GOLDMAN M GRAY C GRAY D GRAY R HANDOLL H HANKEY G HARRISON MJG HENDERSON N HEPTINSTALL S HOBBIGER SF JONES EW JONES NAG JOST S JULIAN D KELLETT J KESTER RC LOWE G MACKENZIE J MCCOLLUM CN MEAD G MEADE TW MENDELOW D MILLER JC MORRIS GK NICHOL C NOBLE M OBRIEN JR OGIER M PARISH S PARRY MJ PETO R POWELL J POZZILLI P QIZILBASH N RAHMAN A RAJAH SM RICHARDS DH RICHARDS S RIPLEY R ROBERTS VC ROSE FC RUSSELL RWR RUBIN PC RUCKLEY CV SANDERCOCK P SHAW MDM SHAW KM SHELLEY JH SLATTERY J SLEIGHT P SMITH SJ STEWARTLONG P SWEETNAM PM TANSEY MJB TINDALL H TURNEY J TYLER HM VAREY NC VESSEY MP WALKER MG WALKER MA WARLOW CP WILCOX RG WILLEMS H WOOD EH WYNJONES E ADAMS HP BARTON B BEDFORD RF BICK BL BINGHAM S BROWN BG BRYANT T BURING J CABOT CF CANNER P CHESEBRO J CHRISMAN OD CLAGETT GP COLWELL JA DYKEN M ELLIS D FIELDS WS FURBERG C FUSTER V GOLDMAN S GRANETT J GREEN RM GREEN D HARDY R HARKER LA HARRIS WH HART RG HASS WK HENNEKENS C HILL D HUME M IGLOE MC JOHNSON G JONAS S KNATTERUD G KOHLER TR LEMBO NJ LEWIS D LOCKHART E MAJERUS P MCENANY MT MCKENNA R MEHTA JL MEYER JS MOLONY B MORITZ T NICOLOFF DM NYCZ G ONO H PANTELY GA PHILLIPS SJ RIDKER P ROBERTSON JT ROTHBART R SALZMAN EW SAUTTER RD SCHLANT RC SCHOENBERGER JA SENGEKONTACKET MV SHARMA G STEELE P STEINNAGEL KP STRATTON J SULLIVAN JM TIMMIS G TOOLE JF WALKER MD WEISMAN S WHITE CW WIRECKI M WOMBOLT D WONG R YUSUF S ZADINA K ZUCKER D
Citation: R. Altman et al., COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS, BMJ. British medical journal, 308(6921), 1994, pp. 81-100
APOLIPOPROTEINS, FIBRINOGEN AND VON-WILLEBRAND-FACTOR AS RISK-FACTORSFOR ISCHEMIC STROKE
Authors: QIZILBASH N PRENTICE CRM DUFFY S DURRINGTON P WARLOW C
Citation: N. Qizilbash et al., APOLIPOPROTEINS, FIBRINOGEN AND VON-WILLEBRAND-FACTOR AS RISK-FACTORSFOR ISCHEMIC STROKE, Thrombosis and haemostasis, 69(6), 1993, pp. 1206-1206
Risultati: 1-11 |